首页> 外文期刊>European journal of medical research. >Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China
【24h】

Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China

机译:宫颈病变中细胞周期蛋白依赖性激酶5的评价及临床意义:中国广西临床研究研究

获取原文
           

摘要

Studies have been reported that cyclin-dependent kinase5 (CDK5) was associated with the development of several cancers. However, the relationship between CDK5 level and clinicopathological factors is still poorly understood in cervical diseases. The aim of the current study was to investigate the expression of CDK5 and its clinical significance in variant cervical lesions. Immunohistochemistry (IHC) was used to detect CDK5 expression in 54 cases of chronic cervicitis, 42 cases of condyloma acuminate (CA), 38 cases of carcinoma in situ, and 360 cases of cervical cancers [adenocarcinoma, n?=?63; squamous cell carcinoma (SCC), n?=?263; adenosquamous carcinoma, n?=?34]. The clinicopathological characteristics in relation to CDK5 were examined by Pearson’s Chi-square test. The positive rates of CDK5 were 27.8, 31.0, 50, 54.0, 58.8, and 62.7?% in chronic cervicitis, CA, carcinoma in situ, adenocarcinoma, adenosquamous carcinoma and SCC, respectively. Statistically analysis showed that CDK5 expression in cervical cancer tissues was higher than non-cervical cancer tissues (inflammation and CA) (P??0.001). The overexpression of CDK5 was significantly correlated with lymph node metastasis (r?=?0.317; P??0.001), histological type (r?=?0.198; P??0.001), FIGO stage (r?=?0.358; P??0.001), TNM stage (r?=?0.329; P??0.001) and pathological grade (r?=?0.259; P??0.001) in cervical lesions evaluated by Pearson’s Chi-square test. Furthermore, the positive relationships were found between CDK5 and lymph node metastasis (P??0.001), FIGO stage (P??0.001), TNM stage (P??0.001) and pathological grade (P??0.001) in SCC. CDK5 was positively interrelated to TNM stage (P?=?0.017) in adenosquamous carcinoma. CDK5 may play a vital role in the development of cervical cancer, which may be a marker for the diagnosis, therapy and prognosis of cervical cancer.
机译:据报道,研究依赖性激酶蛋白酶5(CDK5)与几种癌症的发育有关。然而,CDK5水平与临床病理因子之间的关系仍然在宫颈疾病中理解。目前研究的目的是探讨CDK5的表达及其在变异宫颈病变中的临床意义。免疫组织化学(IHC)用于检测54例慢性宫颈炎病例中的CDK5表达,42例尖锐湿疣(CA),原位癌38例,以及360例宫颈癌[腺癌,N吗?= 63;鳞状细胞癌(SCC),N?=?263;腺瘤性癌,n?= 34]。 Pearson的Chi-Square试验检查了与CDK5相关的临床病理特征。 CDK5的阳性率分别为27.8,31.0,50,54.0,58.8和62.7.7.0,58.8和62.7μm,分别为原位,腺癌,腺癌癌和SCC。统计学分析表明,宫颈癌组织中的CDK5表达高于非宫颈癌组织(炎症和CA)(p?<〜0.001)。 CDK5的过表达与淋巴结转移显着相关(R?= 0.317; p?<〜0.001),组织学型(R?= 0.198; p?<0.001),FOGPO阶段(R?= 0.358; p?<〜0.001),TNM阶段(R?= 0.329; p?<?0.001)和病理级(R?= 0.259;p≤0.259;p≤≤0.259; p?<0.001)通过Pearson的Chi-square测试评估的宫颈病变。此外,在CDK5和淋巴结转移之间发现阳性关系(P?<〜0.001),FOGPO(P?<0.001),TNM阶段(P?<0.001)和病理等级(P?<0.001)在SCC。 CDK5在腺瘤癌中呈态度呈正相关(P?= 0.017)。 CDK5可能在宫颈癌的发展中发挥至关重要的作用,这可能是宫颈癌诊断,治疗和预后的标志物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号